These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

909 related articles for article (PubMed ID: 11442326)

  • 1. Atypical motor neuron disease and related motor syndromes.
    Verma A; Bradley WG
    Semin Neurol; 2001 Jun; 21(2):177-87. PubMed ID: 11442326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.
    Gordon PH; Cheng B; Katz IB; Mitsumoto H; Rowland LP
    Neurology; 2009 Jun; 72(22):1948-52. PubMed ID: 19487653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phenotypes in ALS--clinical features and pathology].
    Sasaki S
    Brain Nerve; 2007 Oct; 59(10):1013-21. PubMed ID: 17969341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Differential diagnosis and atypical subsets of amyotrophic lateral sclerosis].
    Pradat PF; Bruneteau G
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S81-4S90. PubMed ID: 17128093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinsonism and motor neuron diseases: twenty-seven patients with diverse overlap syndromes.
    Gilbert RM; Fahn S; Mitsumoto H; Rowland LP
    Mov Disord; 2010 Sep; 25(12):1868-75. PubMed ID: 20669307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phenotypic variation in ALS].
    Sasaki S
    Rinsho Shinkeigaku; 2006 Nov; 46(11):825-7. PubMed ID: 17432191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Objective markers for upper motor neuron involvement in amyotrophic lateral sclerosis].
    Iwata NK
    Brain Nerve; 2007 Oct; 59(10):1053-64. PubMed ID: 17969345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative objective markers for upper and lower motor neuron dysfunction in ALS.
    Mitsumoto H; Ulug AM; Pullman SL; Gooch CL; Chan S; Tang MX; Mao X; Hays AP; Floyd AG; Battista V; Montes J; Hayes S; Dashnaw S; Kaufmann P; Gordon PH; Hirsch J; Levin B; Rowland LP; Shungu DC
    Neurology; 2007 Apr; 68(17):1402-10. PubMed ID: 17452585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Amyotrophic lateral sclerosis: differential diagnosis and frontier forms].
    Magistris MR
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S67-4S80. PubMed ID: 17128092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyotrophic lateral sclerosis and primary lateral sclerosis: The role of diffusion tensor imaging and other advanced MR-based techniques as objective upper motor neuron markers.
    Wang S; Melhem ER
    Ann N Y Acad Sci; 2005 Dec; 1064():61-77. PubMed ID: 16394148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up.
    Tartaglia MC; Rowe A; Findlater K; Orange JB; Grace G; Strong MJ
    Arch Neurol; 2007 Feb; 64(2):232-6. PubMed ID: 17296839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcallosal inhibition in amyotrophic lateral sclerosis.
    Wittstock M; Wolters A; Benecke R
    Clin Neurophysiol; 2007 Feb; 118(2):301-7. PubMed ID: 17140846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Classical and atypical clinical features in amyotrophic lateral sclerosis].
    Pradat PF; Bruneteau G
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S17-4S24. PubMed ID: 17128085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The natural history of primary lateral sclerosis.
    Gordon PH; Cheng B; Katz IB; Pinto M; Hays AP; Mitsumoto H; Rowland LP
    Neurology; 2006 Mar; 66(5):647-53. PubMed ID: 16534101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Onset and spreading patterns of upper and lower motor neuron symptoms in amyotrophic lateral sclerosis.
    Körner S; Kollewe K; Fahlbusch M; Zapf A; Dengler R; Krampfl K; Petri S
    Muscle Nerve; 2011 May; 43(5):636-42. PubMed ID: 21484822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic challenges in ALS.
    Belsh JM
    Neurology; 1999; 53(8 Suppl 5):S26-30; discussion S35-6. PubMed ID: 10560634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically undetected motor neuron disease in pathologically proven frontotemporal lobar degeneration with motor neuron disease.
    Josephs KA; Parisi JE; Knopman DS; Boeve BF; Petersen RC; Dickson DW
    Arch Neurol; 2006 Apr; 63(4):506-12. PubMed ID: 16606762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of motor neuron disease: classification and nomenclature.
    Bradley WG
    Clin Neurosci; 1995-1996; 3(6):323-6. PubMed ID: 9021252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Motor neuron diseases. Present].
    Pou A
    Neurologia; 1996 Dec; 11 Suppl 5():1-6. PubMed ID: 9044569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity of electrophysiological tests for upper and lower motor neuron dysfunction in ALS: a six-month longitudinal study.
    de Carvalho M; Swash M
    Muscle Nerve; 2010 Feb; 41(2):208-11. PubMed ID: 19697379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.